Save time and get answers to complex questions with AI chat
Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expirationOzempic jordan price 2026Nicardipine brand names
See the DrugPatentWatch profile for flomax
Manufacturer Information The medication Flomax, also known as Tamsulosin, is manufactured by various companies depending on the location and country. In the United States, Flomax is marketed by GlaxoSmithKline [1] under a license agreement with Boehringer Ingelheim [2]. Generic and Biosimilar Options There are several generic and biosimilar versions of Flomax available from various manufacturers, including: * Teva Pharmaceuticals [3] * Sandoz (Novartis) [4] * Mylan [5] * Aurobindo Pharma [6] These generic and biosimilar versions are approved by regulatory agencies such as the US FDA (Food and Drug Administration) and are available in the United States. Patent Status The original patent for Flomax (Tamsulosin) expired in 2006, allowing generic versions to enter the market [7]. The patent landscape for Flomax is complex, with multiple patents expiring and new ones being granted. According to DrugPatentWatch.com [8], the patent for the branded version of Flomax will likely expire in 2025, allowing for further generic competition. References: [1] https://www.gsk.com/en-gb [2] https://www.boehringer-ingelheim.com [3] https://www.tevapharmaceuticals.com [4] https://www.novartis.com [5] https://www.mylan.com [6] https://www.aurobindo.com [7] https://drugpatentwatch.com [8] https://drugpatentwatch.com/patents/US6204066
Other Questions About Flomax :